Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt
· Delayed Price · Currency is EGP 84.50
+1.51 (1.82%)
At close: Apr 28, 2026
EGX:PHAR Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,260 | 13,079 | 6,829 | 5,430 | 3,621 | 4,155 | Upgrade
|
| Market Cap Growth | 89.82% | 91.51% | 25.78% | 49.96% | -12.86% | -3.57% | Upgrade
|
| Enterprise Value | 21,913 | 21,426 | 14,578 | 9,630 | 5,388 | 5,509 | Upgrade
|
| Last Close Price | 84.50 | 74.36 | 41.42 | 31.36 | 22.75 | 24.04 | Upgrade
|
| PE Ratio | 9.51 | 9.07 | 6.23 | 6.60 | 5.63 | 8.52 | Upgrade
|
| Forward PE | 9.77 | 7.03 | 7.03 | 5.92 | 5.77 | 6.23 | Upgrade
|
| PS Ratio | 1.51 | 1.39 | 0.90 | 1.04 | 0.92 | 1.22 | Upgrade
|
| PB Ratio | 2.18 | 2.00 | 1.47 | 1.27 | 1.12 | 1.40 | Upgrade
|
| P/TBV Ratio | 2.30 | 2.11 | 1.48 | 1.28 | 1.12 | 1.40 | Upgrade
|
| P/OCF Ratio | 13.04 | 11.96 | - | 58.71 | - | 10.83 | Upgrade
|
| PEG Ratio | - | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | Upgrade
|
| EV/Sales Ratio | 2.32 | 2.27 | 1.92 | 1.84 | 1.36 | 1.62 | Upgrade
|
| EV/EBITDA Ratio | 7.42 | 8.73 | 9.12 | 7.33 | 7.10 | 6.35 | Upgrade
|
| EV/EBIT Ratio | 7.73 | 9.15 | 9.70 | 7.95 | 8.14 | 7.09 | Upgrade
|
| Debt / Equity Ratio | 1.35 | 1.35 | 1.98 | 1.15 | 0.88 | 0.59 | Upgrade
|
| Debt / EBITDA Ratio | 3.58 | 3.58 | 5.76 | 3.74 | 3.76 | 2.03 | Upgrade
|
| Net Debt / Equity Ratio | 1.13 | 1.13 | 1.70 | 1.00 | 0.73 | 0.49 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.00 | 3.00 | 4.96 | 3.23 | 3.13 | 1.67 | Upgrade
|
| Net Debt / FCF Ratio | -28.20 | -28.20 | -1.92 | -1.93 | -2.77 | -27.25 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.60 | 0.63 | 0.66 | 0.66 | Upgrade
|
| Inventory Turnover | 1.42 | 1.42 | 1.46 | 1.36 | 1.21 | 1.08 | Upgrade
|
| Quick Ratio | 0.66 | 0.66 | 0.45 | 0.65 | 0.54 | 0.67 | Upgrade
|
| Current Ratio | 1.16 | 1.16 | 1.38 | 1.94 | 1.72 | 2.13 | Upgrade
|
| Return on Equity (ROE) | 26.06% | 26.06% | 24.60% | 21.95% | 20.71% | 16.78% | Upgrade
|
| Return on Assets (ROA) | 8.70% | 8.70% | 7.41% | 9.04% | 6.89% | 9.46% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.55% | 14.55% | 10.36% | 13.21% | 10.69% | 14.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.30% | 22.30% | 15.80% | 16.90% | 16.10% | 21.70% | Upgrade
|
| Earnings Yield | 10.11% | 11.02% | 16.04% | 15.14% | 17.76% | 11.74% | Upgrade
|
| FCF Yield | -1.83% | -2.00% | -60.34% | -40.48% | -23.75% | -1.28% | Upgrade
|
| Dividend Yield | 1.73% | - | 3.62% | 3.19% | 4.40% | 6.24% | Upgrade
|
| Payout Ratio | 42.41% | 42.41% | 39.61% | 37.67% | 61.14% | 78.64% | Upgrade
|
| Buyback Yield / Dilution | -8.93% | -9.01% | - | -50.00% | - | -1.64% | Upgrade
|
| Total Shareholder Return | -7.19% | -9.01% | 3.62% | -46.81% | 4.40% | 4.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.